Cargando…

Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancer

PURPOSE: Palliative radiation therapy (RT) can improve quality of life but also incurs time and financial costs. The aim of this study was to evaluate factors associated with use and intensity of palliative RT for incurable non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: This was a retros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lam, Miranda B., Li, Ling, Cronin, Angel, Schrag, Deborah, Chen, Aileen B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Thoracic Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128034/ https://www.ncbi.nlm.nih.gov/pubmed/30202806 http://dx.doi.org/10.1016/j.adro.2018.04.005

Ejemplares similares

Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience
por: Yu, Nathan Y., et al.
Publicado: (2019)

Increases in Serial Pretreatment (18)F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
por: Prionas, Nicolas D., et al.
Publicado: (2018)

Interobserver reliability in describing radiographic lung changes after stereotactic body radiation therapy
por: Kalman, Noah S., et al.
Publicado: (2018)

Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes
por: Sood, Sumit S., et al.
Publicado: (2017)

Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive Impairments
por: Gandhidasan, Senthilkumar, et al.
Publicado: (2019)

Fatal Radiation Pneumonitis: Literature Review and Case Series
por: Keffer, Stephen, et al.
Publicado: (2019)

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution
por: Yegya-Raman, Nikhil, et al.
Publicado: (2019)

Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition
por: von Reibnitz, Donata, et al.
Publicado: (2018)

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
por: Corradetti, Michael N., et al.
Publicado: (2019)

Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial
por: Henke, Lauren E., et al.
Publicado: (2018)

Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non–small cell lung cancer
por: Krantz, Seth B., et al.
Publicado: (2022)

Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes
por: Zou, Zhenwei, et al.
Publicado: (2020)

Intraoperative challenges after induction therapy for non–small cell lung cancer: Effect of nodal disease on technical complexity
por: Feldman, Hope A., et al.
Publicado: (2022)

“Engagement ring” image conveys regrettable outcome for aged patients with non‐small cell lung cancer
por: Yamane, Hiromichi, et al.
Publicado: (2018)

Visualization of patterns of lymph node metastases in non–small cell lung cancer using network analysis
por: Yoshida, Yukihiro, et al.
Publicado: (2022)

Asia expert consensus on segmentectomy in non–small cell lung cancer: A modified Delphi study
por: Liu, Lunxu, et al.
Publicado: (2023)

Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER‐Medicare‐linked data resource
por: Lam, Clara, et al.
Publicado: (2018)

Comparative effectiveness of stereotactic body radiation therapy versus surgery for stage I lung cancer in otherwise healthy patients: An instrumental variable analysis
por: Littau, Michael J., et al.
Publicado: (2022)

Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapy
por: Tang, Andrew, et al.
Publicado: (2022)

Delays to surgery and worse outcomes: The compounding effects of social determinants of health in non–small cell lung cancer
por: Ashrafi, Arman, et al.
Publicado: (2023)

Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines
por: Peng, Terrance, et al.
Publicado: (2022)

Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
por: Ashrafi, Arman, et al.
Publicado: (2023)

Feasibility study of a novel wireless localization technique using radiofrequency identification markers for small and deeply located lung lesions
por: Yutaka, Yojiro, et al.
Publicado: (2022)

Survival after recurrence following surgical resected non-small cell lung cancer: A multicenter, prospective cohort study
por: Takenaka, Tomoyoshi, et al.
Publicado: (2022)

Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumors
por: Peng, Terrance, et al.
Publicado: (2022)

Treatment quality and outcomes vary with hospital burden of uninsured and Medicaid patients with cancer in early non–small cell lung cancer
por: Muslim, Zaid, et al.
Publicado: (2022)

Midterm survival of imaging-assisted robotic lung segmentectomy for non-small-cell lung cancer
por: Chaari, Zied, et al.
Publicado: (2021)

Segmentectomy versus lobectomy for inner-located small-sized early non-small-cell lung cancer
por: Tane, Shinya, et al.
Publicado: (2022)

Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer
por: Wang, Jennifer C., et al.
Publicado: (2022)

Mediastinal radiotherapy after adjuvant chemotherapy for resected non–small cell lung cancer with N2 lymphadenopathy: A novel meta-analysis
por: Harling, Leanne, et al.
Publicado: (2020)

A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707)
por: Kunitoh, Hideo, et al.
Publicado: (2020)

Loss of STING expression is prognostic in non–small cell lung cancer
por: Lohinai, Zoltan, et al.
Publicado: (2022)

Practical aspects of palliative care & palliative radiotherapy in incurable cervical cancer
por: George, Reena, et al.
Publicado: (2021)

Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
por: Eide, Hanne A., et al.
Publicado: (2018)

Patterns of care for older patients with stage IV non‐small cell lung cancer in the immunotherapy era
por: Kehl, Kenneth L., et al.
Publicado: (2020)

Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery
por: ten Berge, Martijn G, et al.
Publicado: (2020)

Impact of Palliative Gastrectomy in Patients with Incurable Gastric Cancer
por: Park, Ji Yeon, et al.
Publicado: (2021)

Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC
por: Arnett, Andrea L.H., et al.
Publicado: (2019)

Feasibility of double sleeve lobectomy after neoadjuvant chemotherapy in patients with non-small-cell lung cancer
por: Bao, Yi, et al.
Publicado: (2022)

Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j8jdmrsi99t015jq53cctjq7b7